MILabs announces the first installation in Poland of its pre-clinical Adaptive microCT scanner

2020-01-15T11:16:06+01:00March 22nd, 2019|News|

The Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology (FBBB) at the Jagiellonian University in Kraków recently became the first institute in Poland to install MILabs’ Adaptive U-CT for in-vivo preclinical imaging. To accommodate the diverse in-vivo imaging needs of the FBBB, including imaging of bones and ossicles plus soft tissues in mice and [...]

Barts Cancer Institute at Queen Mary University of London upgrades its imaging facility with MILabs VECTor PET/SPECT/CT

2019-07-05T10:57:42+02:00March 20th, 2019|News|

Utrecht/London March 20 2019 - Milabs B.V., manufacturer of the world’s only fully integrated SPECT/PET/Optical/CT-scanner, today announces that the core molecular imaging facility at Queen Mary University of London’s Barts Cancer Institute (BCI) has boosted its radionuclide imaging capabilities with a MILabs VECTor PET/SPECT/CT omni-tomography system. Unlike other multi-modality PET/SPECT/CT systems, the VECTor technology enables [...]

Join MILabs at our Industry Session at EMIM

2019-03-12T16:36:36+01:00March 12th, 2019|News|

Next week Thursday, during the EMIM in Glasgow, MILabs will be hosting a free Industry Session. Join us and watch the presentations of: Freek Beekman, MILabs Felix Gremse, RWTH Aachen Behdad Pouran, UMC Utrecht James Knight, Newcastle University René Raavé, Radboud UMC Nijmegen

RWTH Aachen’s ExMI Institute expands molecular imaging capabilities with MILabs’ Integrated Optical/CT system

2019-02-26T09:35:40+01:00February 25th, 2019|News|

Aachen, Germany and Utrecht, the Netherlands – February 25, 2019 MILabs B.V. is pleased to announce that the Institute of Experimental Molecular Imaging (ExMI) at the RWTH Aachen University has chosen the MILabs high resolution CT to further enhance its world-leading molecular imaging research. Together with the new MILabs optical tomography system, this unrivaled hybrid [...]

Scientist in the Spotlight: Dr. Veerle Kersemans, Imaging Core, Department of Oncology of the University of Oxford

2018-10-30T09:46:17+01:00October 8th, 2018|News|

Dr. Veerle Kersemans is the Lead Biological Scientist at the Imaging Core of the Department of Oncology at the University of Oxford. The Imaging Core is equipped with a range of preclinical imaging equipment and radiotherapy instruments and is staffed with biological and physical scientists. The synergistic capabilities of the imaging systems, including the VECTor [...]

MILabs’ VECTor6 with groundbreaking PET performance awarded Innovation of the Year at the WMIC 2018

2018-09-26T15:40:52+02:00September 18th, 2018|News|

September 15, Seattle, USA MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, 2018. The VECTor6 system advances the state of the art of PET imaging by increasing PET resolution down to 0.55 [...]

MILabs Broadband Photon Tomography nominated for Innovation of the Year – WMIC 2018

2018-09-11T09:17:09+02:00September 10th, 2018|News|

September 4, Seattle, USA, and Utrecht, the Netherlands MILabs is pleased to announce that its new Broadband Photon Tomography technique has been nominated for the Innovation of the Year 2018 award by the World Molecular Imaging Society (WMIS) board of trustees. Broadband Photon Tomography as implemented on MILabs’ new VECTor6 platform, dramatically expands the versatility and [...]

University of Sydney acquires state-of-the-art MILabs preclinical in-vivo X-ray CT

2018-09-05T12:27:31+02:00September 3rd, 2018|News|

Sydney, Australia, and Utrecht, the Netherlands, August 31st, 2018 MILabs announces that it has successfully completed the installation of its next-generation Adaptive U-CTXUHR at Sydney Imaging, a Core Research Facility of the University of Sydney. Recognizing that excellence in research is increasingly linked to excellence in infrastructure capability, Sydney Imaging selected MILabs X-ray CT system for [...]

Scientist in the Spotlight: Professor Vesna Sossi, Ph.D., TRIUMF Canada’s Particle Accelerator Centre

2018-09-04T15:20:15+02:00July 30th, 2018|News|

Professor Vesna Sossi, Ph.D. is blazing a trail with her theranostic research program at the University of British Columbia (UBC) and TRIUMF Canada’s Particle Accelerator Centre. As the director of the UBC Positron Emission Tomography (PET) Imaging Laboratory, Dr. Sossi and her colleagues are using the MILabs VECTor PET/SPECT/CT system to characterize and image isotopes in a [...]

The Hebrew University of Jerusalem installs MILabs’ dual-energy, high-resolution microCT for imaging drug delivery.

2018-09-04T15:25:36+02:00July 30th, 2018|News|

Jerusalem, Israel, and Utrecht, the Netherlands, July 30th, 2018 A MILabs dual-energy, ultra-high resolution U-CT system has been installed at the Hebrew University of Jerusalem Israel (HUJI). Under the direction of Professor Galia Blum, this institute has established an internationally renowned research program, focused on drug design, delivery, and therapy.  The Blum Lab uses synthetic [...]

MILabs announced the co-winners of the MILabs Image of the Year Award

2018-09-04T15:28:03+02:00July 12th, 2018|News|

This year MILabs had the pleasure to announce  two winners of the 2018 MILabs Image of the Year Award at the  SNMMI meeting in Philadelphia,  MILabs Founder and CEO  Prof. Dr. Freek Beekman presented these and other exciting  images at the Annual MILabs SNMMI Scientific Event, showcasing a wide diversity of user applications and the [...]

MILabs introduces futuristic PET capabilities on its new VECTor6 system

2018-09-04T15:31:07+02:00June 23rd, 2018|News|

The new VECTor6 imaging system is packed with exclusive preclinical PET imaging features including 0.6 mm 18F resolution,  the elimination of positron-range blurring for e.g. 124I, simultaneous multi-isotope PET and PET/SPECT tomography, and α- and β-radiotherapy imaging. Philadelphia, USA, June 23, 2018. At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26, [...]